Udenafil

Udenafil is a benzenesulfonamide derivative with vasodilatory activity. Udenafil selectively inhibits phosphodiesterase type 5 (PDE5), thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis; inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, and, so, prolonged penile erection. It is grouped under the following drug class(es): PDE5 Inhibitors. Its therapeutic use is listed as sexual dysfunction agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zydena and Udenafilo. Its PubChem CID is 135413547.

CAS No 268203-93-6
Molecular Formula C25H36N6O4S
Molecular Weight 516.70 g/mol
Synonyms 3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide

Frequently Asked Questions